Mobile

A trial comparing stepwise insulin intensification of biphasic insulin aspart (BIAsp) 30 and basal-bolus therapy with insulin glargine and insulin aspart in insulin naïve type 2 diabetic patients inad...

Mise à jour : Il y a 4 ans
Référence : U1111-1158-7280

A trial comparing stepwise insulin intensification of biphasic insulin aspart (BIAsp) 30 and basal-bolus therapy with insulin glargine and insulin aspart in insulin naïve type 2 diabetic patients inadequately controlled on oral anti-diabetic therapy

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To compare the effect of intensification with BIAsp 30 versus intensification with basal bolus insulin analogues (insulin glargine and insulin aspart) on glycaemic control.

Critère d'inclusion

  • Diabetes Mellitus, Type 2

Liens